国家自然科学基金(30370713,30225045)和国家高技术"863"计划资助项目(2004AA227060).
This work was supported by grants from The National Natural Sciences Foundation of China (30370713, 30225045) and National High Tech R&D Program of China (2004AA227060).
对于不存在某单一基因位点经典的孟德尔显性或隐性遗传模式的疾病,称为复杂疾病,肿瘤是最常见的类型之一 . 目前,以连锁和相关分析为基础的功能克隆、功能候选克隆、定位克隆、定位候选克隆、系统生物学等复杂疾病易感基因定位策略逐渐发展起来 . 其中,系统生物学策略由于整合了从 DNA 到蛋白质的各个层面的信息,对复杂疾病基因调控网络做出了良好诠释,使其成为最有潜力的方法之一 . 目前,虽然已有近 100 种肿瘤 / 遗传性癌综合症的易感基因被鉴定出来,但未来的复杂疾病易感基因定位工作仍充满了挑战 .
Complex diseases are the any ones that there is no classical mendelian dominant or recessive inheritance model for a single locus. And cancers are a kind of common complex diseases. Based on the linkage analysis and association analysis, many genetic mapping approaches of complex diseases had been grown up such as functional cloning, candidate cloning, positional cloning, positional candidate cloning and systems biology approach and so on. Among them, systems biology approach is in the ascendant now. Because it integrates all of the informations from DNA to proteins, it gives a better commentary of the complicated gene- regulatory network. This advantage makes it become one of the most potential methods in the 21 century. Nearly one hundred of cancers had been mapped so far. Furthermore, the genetic mappings of complex diseases still shoulder heavy responsibility.
孙玉琳,赵晓航.复杂疾病基因定位策略与肿瘤易感基因鉴定[J].生物化学与生物物理进展,2005,32(9):803-810
复制生物化学与生物物理进展 ® 2025 版权所有 ICP:京ICP备05023138号-1 京公网安备 11010502031771号